Cargando…

Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD

INTRODUCTION: Tubulointerstitial damage in diabetes and chronic kidney disease (CKD) is poorly captured by estimated glomerular filtration rate (eGFR) and albuminuria. Urine biomarkers of kidney health may better elucidate disease progression in persons with diabetes and CKD. METHODS: Per case-cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: Amatruda, Jonathan G., Katz, Ronit, Sarnak, Mark J., Gutierrez, Orlando M., Greenberg, Jason H., Cushman, Mary, Waikar, Sushrut, Parikh, Chirag R., Schelling, Jeffrey R., Jogalekar, Manasi P., Bonventre, Joseph V., Vasan, Ramachandran S., Kimmel, Paul L., Shlipak, Michael G., Ix, Joachim H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263389/
https://www.ncbi.nlm.nih.gov/pubmed/35812302
http://dx.doi.org/10.1016/j.ekir.2022.03.033
_version_ 1784742725149523968
author Amatruda, Jonathan G.
Katz, Ronit
Sarnak, Mark J.
Gutierrez, Orlando M.
Greenberg, Jason H.
Cushman, Mary
Waikar, Sushrut
Parikh, Chirag R.
Schelling, Jeffrey R.
Jogalekar, Manasi P.
Bonventre, Joseph V.
Vasan, Ramachandran S.
Kimmel, Paul L.
Shlipak, Michael G.
Ix, Joachim H.
author_facet Amatruda, Jonathan G.
Katz, Ronit
Sarnak, Mark J.
Gutierrez, Orlando M.
Greenberg, Jason H.
Cushman, Mary
Waikar, Sushrut
Parikh, Chirag R.
Schelling, Jeffrey R.
Jogalekar, Manasi P.
Bonventre, Joseph V.
Vasan, Ramachandran S.
Kimmel, Paul L.
Shlipak, Michael G.
Ix, Joachim H.
author_sort Amatruda, Jonathan G.
collection PubMed
description INTRODUCTION: Tubulointerstitial damage in diabetes and chronic kidney disease (CKD) is poorly captured by estimated glomerular filtration rate (eGFR) and albuminuria. Urine biomarkers of kidney health may better elucidate disease progression in persons with diabetes and CKD. METHODS: Per case-cohort design, we randomly selected a subcohort of 560 study participants of the REasons for Geographic And Racial Differences in Stroke (REGARDS) study from 1092 adults with diabetes and baseline eGFR <60 ml/min per 1.73 m(2) and registered a total of 161 end-stage kidney disease (ESKD) cases (n = 93 from the subcohort; n = 68 from outside the subcohort) during 4.3 ± 2.7 years mean follow-up. We measured urine biomarkers of kidney tubule injury (kidney injury molecule—1 [KIM-1]), inflammation and fibrosis (monocyte chemoattractant protein—1 [MCP-1]), repair (chitinase-3–like protein 1 [YKL-40]), and tubule function, including reabsorption (alpha-1-microglobulin [α1m]) and synthetic capacity (epidermal growth factor [EGF] and uromodulin [UMOD]). Weighted Cox regression models estimated ESKD risk adjusting for demographics, ESKD risk factors, and baseline eGFR and urine albumin. Least absolute shrinkage and selection operator (LASSO) regression identified a subset of biomarkers most strongly associated with ESKD. RESULTS: At baseline, subcohort participants had mean age of 70 ± 9 years, mean eGFR of 40 ±13 ml/min per 1.73 m(2), and median urine albumin-to-creatinine ratio of 33 (interquartile range 10–213) mg/g. Adjusting for baseline eGFR and albuminuria, each 2-fold higher urine KIM-1 (hazard ratio = 1.43 [95% CI: 1.17–1.75]), α1m (hazard ratio = 1.47 [1.19–1.82]), and MCP-1 (hazard ratio = 1.27 [1.06–1.53]) were independently associated with ESKD. LASSO retained KIM-1 and α1m for associations with ESKD. CONCLUSION: Among adults with diabetes and eGFR <60 ml/min per 1.73 m(2), higher urine KIM-1, α1m, and MCP-1 are independently associated with incident ESKD, providing insight into kidney disease progression in persons with diabetes and CKD.
format Online
Article
Text
id pubmed-9263389
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92633892022-07-09 Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD Amatruda, Jonathan G. Katz, Ronit Sarnak, Mark J. Gutierrez, Orlando M. Greenberg, Jason H. Cushman, Mary Waikar, Sushrut Parikh, Chirag R. Schelling, Jeffrey R. Jogalekar, Manasi P. Bonventre, Joseph V. Vasan, Ramachandran S. Kimmel, Paul L. Shlipak, Michael G. Ix, Joachim H. Kidney Int Rep Clinical Research INTRODUCTION: Tubulointerstitial damage in diabetes and chronic kidney disease (CKD) is poorly captured by estimated glomerular filtration rate (eGFR) and albuminuria. Urine biomarkers of kidney health may better elucidate disease progression in persons with diabetes and CKD. METHODS: Per case-cohort design, we randomly selected a subcohort of 560 study participants of the REasons for Geographic And Racial Differences in Stroke (REGARDS) study from 1092 adults with diabetes and baseline eGFR <60 ml/min per 1.73 m(2) and registered a total of 161 end-stage kidney disease (ESKD) cases (n = 93 from the subcohort; n = 68 from outside the subcohort) during 4.3 ± 2.7 years mean follow-up. We measured urine biomarkers of kidney tubule injury (kidney injury molecule—1 [KIM-1]), inflammation and fibrosis (monocyte chemoattractant protein—1 [MCP-1]), repair (chitinase-3–like protein 1 [YKL-40]), and tubule function, including reabsorption (alpha-1-microglobulin [α1m]) and synthetic capacity (epidermal growth factor [EGF] and uromodulin [UMOD]). Weighted Cox regression models estimated ESKD risk adjusting for demographics, ESKD risk factors, and baseline eGFR and urine albumin. Least absolute shrinkage and selection operator (LASSO) regression identified a subset of biomarkers most strongly associated with ESKD. RESULTS: At baseline, subcohort participants had mean age of 70 ± 9 years, mean eGFR of 40 ±13 ml/min per 1.73 m(2), and median urine albumin-to-creatinine ratio of 33 (interquartile range 10–213) mg/g. Adjusting for baseline eGFR and albuminuria, each 2-fold higher urine KIM-1 (hazard ratio = 1.43 [95% CI: 1.17–1.75]), α1m (hazard ratio = 1.47 [1.19–1.82]), and MCP-1 (hazard ratio = 1.27 [1.06–1.53]) were independently associated with ESKD. LASSO retained KIM-1 and α1m for associations with ESKD. CONCLUSION: Among adults with diabetes and eGFR <60 ml/min per 1.73 m(2), higher urine KIM-1, α1m, and MCP-1 are independently associated with incident ESKD, providing insight into kidney disease progression in persons with diabetes and CKD. Elsevier 2022-04-05 /pmc/articles/PMC9263389/ /pubmed/35812302 http://dx.doi.org/10.1016/j.ekir.2022.03.033 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Clinical Research
Amatruda, Jonathan G.
Katz, Ronit
Sarnak, Mark J.
Gutierrez, Orlando M.
Greenberg, Jason H.
Cushman, Mary
Waikar, Sushrut
Parikh, Chirag R.
Schelling, Jeffrey R.
Jogalekar, Manasi P.
Bonventre, Joseph V.
Vasan, Ramachandran S.
Kimmel, Paul L.
Shlipak, Michael G.
Ix, Joachim H.
Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD
title Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD
title_full Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD
title_fullStr Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD
title_full_unstemmed Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD
title_short Biomarkers of Kidney Tubule Disease and Risk of End-Stage Kidney Disease in Persons With Diabetes and CKD
title_sort biomarkers of kidney tubule disease and risk of end-stage kidney disease in persons with diabetes and ckd
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263389/
https://www.ncbi.nlm.nih.gov/pubmed/35812302
http://dx.doi.org/10.1016/j.ekir.2022.03.033
work_keys_str_mv AT amatrudajonathang biomarkersofkidneytubulediseaseandriskofendstagekidneydiseaseinpersonswithdiabetesandckd
AT katzronit biomarkersofkidneytubulediseaseandriskofendstagekidneydiseaseinpersonswithdiabetesandckd
AT sarnakmarkj biomarkersofkidneytubulediseaseandriskofendstagekidneydiseaseinpersonswithdiabetesandckd
AT gutierrezorlandom biomarkersofkidneytubulediseaseandriskofendstagekidneydiseaseinpersonswithdiabetesandckd
AT greenbergjasonh biomarkersofkidneytubulediseaseandriskofendstagekidneydiseaseinpersonswithdiabetesandckd
AT cushmanmary biomarkersofkidneytubulediseaseandriskofendstagekidneydiseaseinpersonswithdiabetesandckd
AT waikarsushrut biomarkersofkidneytubulediseaseandriskofendstagekidneydiseaseinpersonswithdiabetesandckd
AT parikhchiragr biomarkersofkidneytubulediseaseandriskofendstagekidneydiseaseinpersonswithdiabetesandckd
AT schellingjeffreyr biomarkersofkidneytubulediseaseandriskofendstagekidneydiseaseinpersonswithdiabetesandckd
AT jogalekarmanasip biomarkersofkidneytubulediseaseandriskofendstagekidneydiseaseinpersonswithdiabetesandckd
AT bonventrejosephv biomarkersofkidneytubulediseaseandriskofendstagekidneydiseaseinpersonswithdiabetesandckd
AT vasanramachandrans biomarkersofkidneytubulediseaseandriskofendstagekidneydiseaseinpersonswithdiabetesandckd
AT kimmelpaull biomarkersofkidneytubulediseaseandriskofendstagekidneydiseaseinpersonswithdiabetesandckd
AT shlipakmichaelg biomarkersofkidneytubulediseaseandriskofendstagekidneydiseaseinpersonswithdiabetesandckd
AT ixjoachimh biomarkersofkidneytubulediseaseandriskofendstagekidneydiseaseinpersonswithdiabetesandckd
AT biomarkersofkidneytubulediseaseandriskofendstagekidneydiseaseinpersonswithdiabetesandckd